BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 29665824)

  • 1. Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study.
    Haroon M; Ahmad M; Baig MN; Mason O; Rice J; FitzGerald O
    Arthritis Res Ther; 2018 Apr; 20(1):73. PubMed ID: 29665824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.
    Gladman DD; Mease PJ; Bird P; Soriano ER; Chakravarty SD; Shawi M; Xu S; Quinn ST; Gong C; Leibowitz E; Poddubnyy D; Tam LS; Helliwell PS; Kavanaugh A; Deodhar A; Østergaard M; Baraliakos X
    Trials; 2022 Sep; 23(1):743. PubMed ID: 36064592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis.
    Kılıç G; Kılıç E; Nas K; Karkucak M; Çapkın E; Dağlı AZ; Çevik R; Özgöçmen S
    Clin Rheumatol; 2015 Mar; 34(3):515-21. PubMed ID: 24985042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the Bath Ankylosing Spondylitis Disease Activity Index in Patients With Psoriatic Arthritis With and Without Axial Disease.
    Reddy SM; Xue K; Husni ME; Scher JU; Stephens-Shields AJ; Goel N; Koplin J; Craig ET; Walsh JA; Ogdie A
    J Rheumatol; 2024 Feb; 51(2):139-143. PubMed ID: 38101918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials.
    Helliwell PS; Gladman DD; Chakravarty SD; Kafka S; Karyekar CS; You Y; Campbell K; Sweet K; Kavanaugh A; Gensler LS
    RMD Open; 2020 Feb; 6(1):. PubMed ID: 32209721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies.
    Baraliakos X; Ranza R; Östör A; Ciccia F; Coates LC; Rednic S; Walsh JA; Douglas K; Gao T; Kato K; Song IH; Ganz F; Deodhar A
    Arthritis Res Ther; 2023 Apr; 25(1):56. PubMed ID: 37038159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet to albumin ratio is an independent indicator for disease activity in ankylosing spondylitis.
    Cui R; Wang YL; Tao YL; Tong Q; Chen Z; Dai SM
    Clin Rheumatol; 2023 Feb; 42(2):407-413. PubMed ID: 36414863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial.
    Li Q; Li L; Bi L; Xiao C; Lin Z; Cao S; Liao Z; Gu J
    Trials; 2016 Jul; 17(1):337. PubMed ID: 27449221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic axial spondyloarthritis and ankylosing spondylitis.
    Osterhaus JT; Purcaru O
    Arthritis Res Ther; 2014 Aug; 16(4):R164. PubMed ID: 25099160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?
    Eder L; Chandran V; Shen H; Cook RJ; Gladman DD
    Ann Rheum Dis; 2010 Dec; 69(12):2160-4. PubMed ID: 20627946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
    Tsang HHL; Chung HY
    J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?
    Feld J; Ye JY; Chandran V; Inman RD; Haroon N; Cook R; Gladman DD
    Rheumatology (Oxford); 2020 Jun; 59(6):1340-1346. PubMed ID: 31593590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dactylitis Is Associated With More Severe Axial Joint Damage and Higher Disease Activity in Axial Psoriatic Arthritis.
    Li SS; Du N; He SH; Liang X; Li TF
    J Rheumatol; 2022 Sep; 49(9):1012-1019. PubMed ID: 35501145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2.
    Deodhar A; Gladman D; Bolce R; Sandoval D; Park SY; Leage SL; Nash P; Poddubnyy D
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X231189005. PubMed ID: 37645684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2).
    Kavanaugh A; Puig L; Gottlieb AB; Ritchlin C; You Y; Li S; Song M; Randazzo B; Rahman P; McInnes IB
    Ann Rheum Dis; 2016 Nov; 75(11):1984-1988. PubMed ID: 27098404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis.
    Paramarta JE; De Rycke L; Heijda TF; Ambarus CA; Vos K; Dinant HJ; Tak PP; Baeten DL
    Ann Rheum Dis; 2013 Nov; 72(11):1793-9. PubMed ID: 23139265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA.
    Regierer AC; Weiß A; Proft F; Baraliakos X; Behrens F; Poddubnyy D; Schett G; Lorenz HM; Worsch M; Strangfeld A
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36898762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Back pain in psoriatic arthritis: defining prevalence, characteristics and performance of inflammatory back pain criteria in psoriatic arthritis.
    Yap KS; Ye JY; Li S; Gladman DD; Chandran V
    Ann Rheum Dis; 2018 Nov; 77(11):1573-1577. PubMed ID: 30077991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of SPARCC sacroiliac MRI scoring in axial psoriatic arthritis and its association with other disease parameters.
    Gezer HH; Duruöz MT
    Int J Rheum Dis; 2022 Apr; 25(4):433-439. PubMed ID: 35080124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence, Efficacy, and Safety of Wearable Technology-Assisted Combined Home-Based Exercise in Chinese Patients With Ankylosing Spondylitis: Randomized Pilot Controlled Clinical Trial.
    Wang Y; Liu X; Wang W; Shi Y; Ji X; Hu L; Wang L; Yin Y; Xie S; Zhu J; Zhang J; Jiao W; Huang F
    J Med Internet Res; 2022 Jan; 24(1):e29703. PubMed ID: 35040798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.